CRIS Current Research Information System

GIONCHETTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.615
AS - Asia 9.437
EU - Europa 8.896
AF - Africa 807
SA - Sud America 795
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 32.569
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.436
SG - Singapore 2.810
CN - Cina 2.750
GB - Regno Unito 1.948
IT - Italia 1.824
VN - Vietnam 1.726
DE - Germania 1.174
SE - Svezia 1.055
HK - Hong Kong 852
BR - Brasile 597
RU - Federazione Russa 564
IN - India 505
UA - Ucraina 440
IE - Irlanda 404
FR - Francia 388
KR - Corea 303
NL - Olanda 258
CI - Costa d'Avorio 205
TG - Togo 174
ZA - Sudafrica 174
SC - Seychelles 163
FI - Finlandia 144
CH - Svizzera 141
JP - Giappone 139
BG - Bulgaria 138
EE - Estonia 130
JO - Giordania 117
AR - Argentina 100
BE - Belgio 71
CA - Canada 71
AT - Austria 50
ID - Indonesia 50
PL - Polonia 49
HN - Honduras 37
MX - Messico 37
IR - Iran 32
GR - Grecia 29
ES - Italia 28
EC - Ecuador 27
BD - Bangladesh 25
NG - Nigeria 25
CD - Congo 24
CL - Cile 19
CO - Colombia 18
BZ - Belize 17
PY - Paraguay 16
IQ - Iraq 15
TR - Turchia 15
UZ - Uzbekistan 14
LT - Lituania 12
AU - Australia 11
CZ - Repubblica Ceca 11
KZ - Kazakistan 10
RO - Romania 10
AZ - Azerbaigian 9
MY - Malesia 9
HR - Croazia 8
LB - Libano 8
VE - Venezuela 8
EG - Egitto 7
PH - Filippine 7
TN - Tunisia 7
KE - Kenya 6
MA - Marocco 6
TW - Taiwan 6
BO - Bolivia 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
IL - Israele 4
PE - Perù 4
PK - Pakistan 4
DK - Danimarca 3
JM - Giamaica 3
NO - Norvegia 3
PT - Portogallo 3
AG - Antigua e Barbuda 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
EU - Europa 1
GA - Gabon 1
Totale 32.546
Salva come PNG Salva come JPEG
Città #
Singapore 1.962
Southend 1.642
Ashburn 1.416
Fairfield 1.282
Chandler 1.042
Hong Kong 845
Hefei 704
Santa Clara 632
Woodbridge 616
Seattle 538
Wilmington 538
Houston 531
Princeton 514
Dong Ket 444
Cambridge 419
Beijing 412
Dublin 404
Bologna 356
Ann Arbor 353
Boardman 319
Ho Chi Minh City 312
Seoul 290
Hanoi 257
Jacksonville 242
Abidjan 205
Nanjing 197
Lomé 174
Westminster 174
Los Angeles 170
Berlin 168
Padova 153
Milan 144
New York 139
Sofia 133
Tokyo 123
Buffalo 122
Bern 121
Amman 117
San Diego 105
Frankfurt am Main 104
Helsinki 101
Dallas 100
Redondo Beach 87
Jinan 79
Bengaluru 78
Turin 77
Saint Petersburg 76
Shenyang 76
Brescia 65
Changsha 65
Guangzhou 65
Rome 65
Hebei 60
Munich 60
São Paulo 59
Phoenix 56
Mülheim 51
Nuremberg 51
Yubileyny 51
Brussels 50
Redwood City 50
Falkenstein 48
Nanchang 47
Chicago 42
Medford 42
Redmond 42
Bremen 41
Shanghai 39
London 38
Tianjin 37
Dearborn 36
Florence 35
Haiphong 34
Henderson 34
Jiaxing 34
Des Moines 33
Falls Church 33
Washington 31
Mahé 29
Olalla 29
Lappeenranta 27
Zhengzhou 27
Centro 26
Norwalk 25
Warsaw 25
Amsterdam 24
Da Nang 24
Ha Long 24
Haikou 24
Atlanta 23
Johannesburg 23
Lubumbashi 23
Quận Bình Thạnh 23
Thái Nguyên 23
Brooklyn 22
Montreal 22
Saint Louis 22
Brierley Hill 21
Poplar 21
Rio de Janeiro 21
Totale 21.015
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 559
Ulcerative Colitis 311
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 274
COVID-19 in IBD: The experience of a single tertiary IBD center 257
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 243
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 218
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 213
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 209
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 209
Adult attachment and early parental experiences in patients with Crohn’s Disease 208
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 205
Adalimumab in active ulcerative colitis: a "real-life" observational study. 202
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 202
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 200
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 195
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 193
Infliximab in the treatment of Crohn's disease 191
Attachment and quality of life in patients with inflammatory bowel disease 188
Medical treatment and management of severe ulcerative colitis 186
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 186
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 185
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 183
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 182
High-dose probiotics for the treatment of active pouchitis 180
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 180
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 179
Influence of steroid treatment's duration in patients with active Crohn's disease 179
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 177
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 175
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 175
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 173
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 173
Clinical course of microscopic colitis in a single-center cohort study 172
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 171
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 170
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 170
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 169
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. 168
Clinical guidelines for the management of pouchitis 168
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 167
Management and treatment of distal ulcerative colitis 166
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 165
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 162
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 162
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment 162
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 161
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 161
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 161
Implications of antioxidant enzymes in human gastric neoplasms 160
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 159
Antibiotics and probiotics in treatment of inflammatory bowel disease 159
Oral budesonide in the treatment of chronic refractory pouchitis. 158
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. 157
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 156
Review article: aminosalicylates for distal colitis 154
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 154
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 153
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 151
Management of inflammatory bowel disease: does rifaximin offer any promises 151
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 150
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 150
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease 150
Role of Biologics in refractory pouchitis 149
Role of conventional therapies in the era of biological treatment in Crohn's disease. 149
Which therapies are advisable in pouchitis? 148
Antimicrobials in the management of inflammatory bowel disease 148
The role of Budesonide-MMX in active ulcerative colitis. 148
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 147
Parental Bonding and Inflammatory Bowel Disease 147
MANAGEMENT OF POUCHITIS 147
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 146
Probiotics in IBD: A critical review 146
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 145
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 145
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 145
Randomized controlled trials in pouchitis 144
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 144
Sympathetic hyperactivity in patients with ulcerative colitis. 143
Pre-pouch ileitis 142
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 142
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 142
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 141
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 141
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 139
Problematic proctitis and distal colitis 139
Probiotics, Prebiotics, and Antibiotics in IBD 138
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 138
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 137
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 137
Oral beclomethasone dipropionate in chronic refractory pouchitis 137
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 137
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 137
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 137
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 136
Implications of the westernized diet in the onset and progression of IBD 135
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 134
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 134
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. 133
A current overview of corticosteroid use in active ulcerative colitis 133
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 133
Totale 16.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.117 0 0 0 0 0 172 140 281 312 244 120 848
2021/20224.114 431 114 247 182 332 178 98 227 331 293 1.079 602
2022/20234.892 505 745 248 551 319 387 141 286 898 141 340 331
2023/20241.530 107 237 137 111 125 358 78 91 40 110 60 76
2024/20255.994 296 834 478 382 929 305 447 208 142 408 318 1.247
2025/20267.046 1.385 1.564 1.335 1.084 1.580 98 0 0 0 0 0 0
Totale 33.439